WeberLabWUSTL

Cancer biology laboratory at Washington University in St. Louis School of Medicine, Division of Oncology, Department of Medicine.

[WeberLabWUSTL @WeberLabWUSTL]

@KyleCottrell @biorxivpreprint @Sua_Ryu Great job @KyleCottrell and @Sua_Ryu on a very difficult and seemingly endless project.

[Kyle Cottrell @KyleCottrell]

Very excited about our latest @biorxivpreprint. This is the outcome of a joint project between myself and @Sua_Ryu. What started as a side project a few years ago has morphed into one of the most interesting projects I've ever worked on. 1/13 https://t.co/s4JeRWAtnb

[WeberLabWUSTL @WeberLabWUSTL]

@KyleCottrell is presenting our work on ADAR in triple-negatvie breast cancer at @RNASociety #RNA2020. Very much a team effort by many in the lab @BetelNut_Wustl @sua_r2507 @EmilyBramel @CncrKlr

[Kyle Cottrell @KyleCottrell]

If you are participating in the @RNASociety #RNA2020 and want to learn about targeting ADAR to treat triple-negative breast cancer, checkout poster 257 "Evaluating the therapeutic potential of ADAR inhibition for triple-negative breast cancer".

[Kyle Cottrell @KyleCottrell]

Sorry we didn't get to meet today @LacyClayMO1. Please stop by the @WeberLabWUSTL sometime to learn more about the exciting cancer research going on @WUSTLmed. #AACRontheHill #AACRECR20

[WeberLabWUSTL @WeberLabWUSTL]

So very proud of lab alum Dr. Crystal Winkeler who was just named to St. Louis' top 40 under 40 in the St. Louis Business Journal for her startup company Canopy Biosciences!

[Kyle Cottrell @KyleCottrell]

New preprint out today! This one could really benefit from some community comments. Congrats on your first manuscript @chiouey! @WeberLabWUSTL

[WeberLabWUSTL @WeberLabWUSTL]

First tweet = new preprint from the lab! Fantastic work by all of the authors! @BetelNut_Wustl @KyleCottrell @EmilyBramel @CncrKlr ADAR1 editing dependency in triple-negative breast cancer https://t.co/uN48ZckXG4